194 related articles for article (PubMed ID: 28098199)
1. Optogenetic Modulation of Urinary Bladder Contraction for Lower Urinary Tract Dysfunction.
Park JH; Hong JK; Jang JY; An J; Lee KS; Kang TM; Shin HJ; Suh JF
Sci Rep; 2017 Jan; 7():40872. PubMed ID: 28098199
[TBL] [Abstract][Full Text] [Related]
2. Direct optogenetic stimulation of smooth muscle cells to control gastric contractility.
Vogt M; Schulz B; Wagdi A; Lebert J; van Belle GJ; Christoph J; Bruegmann T; Patejdl R
Theranostics; 2021; 11(11):5569-5584. PubMed ID: 33859764
[No Abstract] [Full Text] [Related]
3. Defining the ionic mechanisms of optogenetic control of vascular tone by channelrhodopsin-2.
Rorsman NJG; Ta CM; Garnett H; Swietach P; Tammaro P
Br J Pharmacol; 2018 Jun; 175(11):2028-2045. PubMed ID: 29486056
[TBL] [Abstract][Full Text] [Related]
4. Optogenetic activation of muscle contraction
Ganji E; Chan CS; Ward CW; Killian ML
Connect Tissue Res; 2021 Jan; 62(1):15-23. PubMed ID: 32777957
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 excitatory effects on rat urinary bladder: a comparison between the β-adrenoceptor modulation of non-voiding activity in vivo and micro-contractile activity in vitro.
Granato C; Korstanje C; Guilloteau V; Rouget C; Palea S; Gillespie JI
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jul; 388(7):727-35. PubMed ID: 26063630
[TBL] [Abstract][Full Text] [Related]
6. Optogenetic control of contractile function in skeletal muscle.
Bruegmann T; van Bremen T; Vogt CC; Send T; Fleischmann BK; Sasse P
Nat Commun; 2015 Jun; 6():7153. PubMed ID: 26035411
[TBL] [Abstract][Full Text] [Related]
7. Ryanodine receptor type 2 deficiency changes excitation-contraction coupling and membrane potential in urinary bladder smooth muscle.
Hotta S; Morimura K; Ohya S; Muraki K; Takeshima H; Imaizumi Y
J Physiol; 2007 Jul; 582(Pt 2):489-506. PubMed ID: 17363382
[TBL] [Abstract][Full Text] [Related]
8. Human urinary bladder smooth muscle is dependent on membrane cholesterol for cholinergic activation.
Shakirova Y; Mori M; Ekman M; Erjefält J; Uvelius B; Swärd K
Eur J Pharmacol; 2010 May; 634(1-3):142-8. PubMed ID: 20176011
[TBL] [Abstract][Full Text] [Related]
9. Cardiac optogenetics.
Abilez OJ
Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():1386-9. PubMed ID: 23366158
[TBL] [Abstract][Full Text] [Related]
10. Optogenetic Neuromodulation of the Urinary Bladder.
Zhou Z; Liao L
Neuromodulation; 2021 Oct; 24(7):1229-1236. PubMed ID: 34375470
[TBL] [Abstract][Full Text] [Related]
11. Spectrally distinct channelrhodopsins for two-colour optogenetic peripheral nerve stimulation.
Maimon BE; Sparks K; Srinivasan S; Zorzos AN; Herr HM
Nat Biomed Eng; 2018 Jul; 2(7):485-496. PubMed ID: 30948823
[TBL] [Abstract][Full Text] [Related]
12. Effects of drugs of abuse on channelrhodopsin-2 function.
Gioia DA; Xu M; Wayman WN; Woodward JJ
Neuropharmacology; 2018 Jun; 135():316-327. PubMed ID: 29580953
[TBL] [Abstract][Full Text] [Related]
13. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization.
Gopalakrishnan M; Buckner SA; Whiteaker KL; Shieh CC; Molinari EJ; Milicic I; Daza AV; Davis-Taber R; Scott VE; Sellers D; Chess-Williams R; Chapple CR; Liu Y; Liu D; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ
J Pharmacol Exp Ther; 2002 Oct; 303(1):379-86. PubMed ID: 12235274
[TBL] [Abstract][Full Text] [Related]
14. Optical mapping of optogenetically shaped cardiac action potentials.
Park SA; Lee SR; Tung L; Yue DT
Sci Rep; 2014 Aug; 4():6125. PubMed ID: 25135113
[TBL] [Abstract][Full Text] [Related]
15. Effect of tetrodotoxin on the phasic and tonic responses of isolated rabbit urinary bladder smooth muscle to field stimulation.
Tammela TL; Wein AJ; Levin RM
J Urol; 1992 Dec; 148(6):1937-40. PubMed ID: 1433649
[TBL] [Abstract][Full Text] [Related]
16. Optogenetic Induction of Colonic Motility in Mice.
Hibberd TJ; Feng J; Luo J; Yang P; Samineni VK; Gereau RW; Kelley N; Hu H; Spencer NJ
Gastroenterology; 2018 Aug; 155(2):514-528.e6. PubMed ID: 29782847
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel optogenetic indicator based on cellular deformations for mapping optogenetic activities.
Li G; Yang J; Wang Y; Wang W; Liu L
Nanoscale; 2018 Dec; 10(45):21046-21051. PubMed ID: 30276394
[TBL] [Abstract][Full Text] [Related]
18. Optogenetic tools for modulating and probing the epileptic network.
Zhao M; Alleva R; Ma H; Daniel AG; Schwartz TH
Epilepsy Res; 2015 Oct; 116():15-26. PubMed ID: 26354163
[TBL] [Abstract][Full Text] [Related]
19. The Spatial Extent of Optogenetic Silencing in Transgenic Mice Expressing Channelrhodopsin in Inhibitory Interneurons.
Babl SS; Rummell BP; Sigurdsson T
Cell Rep; 2019 Oct; 29(5):1381-1395.e4. PubMed ID: 31665647
[TBL] [Abstract][Full Text] [Related]
20. 2-Aminoethoxydiphenyl borate causes dissociation between membrane electrical and mechanical activity in guinea-pig urinary bladder smooth muscle.
Imai T; Tanaka Y; Okamoto T; Horinouchi T; Tanaka H; Koike K; Shigenobu K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):282-5. PubMed ID: 12172712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
